Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q2- Text added to 2014 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adequacy, ahead, appeal, biopharmaceutical, biotechnology, comment, complaint, confirmed, Depomed, disposition, District, DoD, explicitly, fill, footnote, inclusion, injury, King, lawsuit, minimal, misleading, monetization, monetize, Northern, notified, pilot, preapproval, President, protracted, respond, reversed, revised, Richard, settle, SOP, Takeda, teleconference, trauma, unspecified, vigorously
Removed:
Akela, diversion, goal, Nycomed, Pharma, significance, TAIFUN
Valuein 2014 Q2 filing- Value in 2014 Q3 filing
Original filings
Filing view